SG80028A1 - Active hedgehog protein conjugate, process for its production and use - Google Patents

Active hedgehog protein conjugate, process for its production and use

Info

Publication number
SG80028A1
SG80028A1 SG9902117A SG1999002117A SG80028A1 SG 80028 A1 SG80028 A1 SG 80028A1 SG 9902117 A SG9902117 A SG 9902117A SG 1999002117 A SG1999002117 A SG 1999002117A SG 80028 A1 SG80028 A1 SG 80028A1
Authority
SG
Singapore
Prior art keywords
hedgehog protein
production
hydrophobic
protein conjugate
amino acids
Prior art date
Application number
SG9902117A
Other languages
English (en)
Inventor
Angelika Esswein
Kurt Lang
Petra Rueger
Tilmann Seytter
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP98107911A external-priority patent/EP0953575A1/de
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of SG80028A1 publication Critical patent/SG80028A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2/00Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG9902117A 1998-04-30 1999-04-28 Active hedgehog protein conjugate, process for its production and use SG80028A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98107911A EP0953575A1 (de) 1998-04-30 1998-04-30 Aktives Hedgehog-Protein-Konjugat, Verfahren zur Herstellung und Verwendung
EP98116733 1998-09-03

Publications (1)

Publication Number Publication Date
SG80028A1 true SG80028A1 (en) 2001-04-17

Family

ID=26149214

Family Applications (1)

Application Number Title Priority Date Filing Date
SG9902117A SG80028A1 (en) 1998-04-30 1999-04-28 Active hedgehog protein conjugate, process for its production and use

Country Status (18)

Country Link
US (4) US6468978B1 (no)
EP (2) EP1557427A3 (no)
JP (1) JP3433136B2 (no)
KR (1) KR19990083621A (no)
CN (1) CN1233616A (no)
AT (1) ATE308563T1 (no)
AU (1) AU719797B2 (no)
CA (1) CA2269221A1 (no)
CY (1) CY1105683T1 (no)
DE (1) DE69928040T2 (no)
DK (1) DK0953576T3 (no)
ES (1) ES2252886T3 (no)
HU (1) HUP9901411A2 (no)
IL (1) IL129620A (no)
MA (1) MA26625A1 (no)
NO (1) NO992090L (no)
NZ (1) NZ335385A (no)
SG (1) SG80028A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL136230A0 (en) * 1997-11-28 2001-05-20 Roche Diagnostics Gmbh An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
US6897297B1 (en) * 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
DK0953576T3 (da) * 1998-04-30 2006-03-20 Curis Inc Aktivt hedgehog-proteinkonjugat, fremgangsmåde til fremstilling heraf og anvendelse
ATE310531T1 (de) * 1998-08-07 2005-12-15 Stabilisierte pharmazeutische zusammensetzungen von hedgehog-proteinen und deren verwendung
TW570805B (en) * 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
JP2003524388A (ja) * 1998-12-03 2003-08-19 バイオジェン インコーポレイテッド 興奮毒性を含む疾患を治療するための方法及び組成物
EP1025861A1 (de) * 1999-02-04 2000-08-09 Roche Diagnostics GmbH Pharmazeutische Zusammensetzung von hydrophob modifizierten Hedgehog-Proteinen und deren Verwendung
AU782493B2 (en) * 1999-06-01 2005-08-04 Curis, Inc. Polymer conjugates of hedgehog proteins and uses
AU2001255767A1 (en) * 2000-04-28 2001-11-12 Curis, Inc. Methods and reagents for tissue engineering of cartilage in vitro
US7573637B2 (en) * 2004-08-03 2009-08-11 Seiko Epson Corporation Intrinsic polarizer and method of manufacturing an intrinsic polarizer
US8669418B2 (en) * 2005-12-22 2014-03-11 Vib Vzw Means and methods for mediating protein interference
US20100316566A1 (en) * 2008-02-27 2010-12-16 Radiomedix Inc. Radiolabeled hedgehog derivatives for imaging and therapy
WO2010065908A2 (en) * 2008-12-05 2010-06-10 Catchmark Jeffrey M Degradable biomolecule compositions
US20110086236A1 (en) * 2009-10-13 2011-04-14 The Penn State Research Foundation Composites containing polypeptides attached to polysaccharides and molecules
RU2637085C2 (ru) * 2011-06-06 2017-11-29 КИНЕТА УАН, ЭлЭлСи Фармацевтические композиции на основе shk и способы их получения и использования
EP3024887B1 (en) 2013-07-26 2023-11-22 The Penn State Research Foundation Method for preparation of polymer compositions and coatings
EP3384935A4 (en) * 2015-12-02 2019-08-21 Hanmi Pharm. Co., Ltd. PROTEIN COMPLEX UTILIZING A FATTY ACID DERIVATIVE, AND PROCESS FOR PREPARING THE SAME

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844079A (en) * 1993-12-30 1998-12-01 President And Fellows Of Harvard College Vertebrate embryonic pattern-inducing proteins, and uses related thereto

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364839A (en) * 1990-06-18 1994-11-15 Genetics Institute, Inc. Osteoinductive pharmaceutical formulations
JP3356775B2 (ja) * 1990-11-30 2002-12-16 セルトリックス ファーマシューティカルズ, インコーポレイテッド TGF―βとの共同的組合せによる骨修復のための骨形成タンパク質の使用
EP0741783B1 (en) * 1993-12-30 2009-03-18 President And Fellows Of Harvard College Vertebrate embryonic pattern-inducing hedgehog-like proteins
US6281332B1 (en) * 1994-12-02 2001-08-28 The Johns Hopkins University School Of Medicine Hedgehog-derived polypeptides
US5700774A (en) * 1996-03-26 1997-12-23 Genetics Institute, Inc. Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same
GB9614871D0 (en) 1996-07-15 1996-09-04 Smithkline Beecham Plc Compounds
WO1998030576A1 (en) * 1996-10-07 1998-07-16 The Johns Hopkins University School Of Medicine Novel hedgehog-derived polypeptides
IL136230A0 (en) * 1997-11-28 2001-05-20 Roche Diagnostics Gmbh An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
US6897297B1 (en) * 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
DE69830192T2 (de) * 1997-12-03 2006-01-12 Biogen Idec Ma Inc., Cambridge Hydrophobisch-modifizierte Hedgehog Protein Zusammensetzungen und Verfahren
DK0953576T3 (da) * 1998-04-30 2006-03-20 Curis Inc Aktivt hedgehog-proteinkonjugat, fremgangsmåde til fremstilling heraf og anvendelse
ATE310531T1 (de) * 1998-08-07 2005-12-15 Stabilisierte pharmazeutische zusammensetzungen von hedgehog-proteinen und deren verwendung
AU2001255767A1 (en) * 2000-04-28 2001-11-12 Curis, Inc. Methods and reagents for tissue engineering of cartilage in vitro

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844079A (en) * 1993-12-30 1998-12-01 President And Fellows Of Harvard College Vertebrate embryonic pattern-inducing proteins, and uses related thereto

Also Published As

Publication number Publication date
KR19990083621A (ko) 1999-11-25
DK0953576T3 (da) 2006-03-20
AU719797B2 (en) 2000-05-18
HU9901411D0 (en) 1999-07-28
ATE308563T1 (de) 2005-11-15
ES2252886T3 (es) 2006-05-16
EP1557427A2 (en) 2005-07-27
IL129620A0 (en) 2000-02-29
US7153836B2 (en) 2006-12-26
CY1105683T1 (el) 2010-12-22
AU2500999A (en) 1999-11-11
US20050148510A1 (en) 2005-07-07
CN1233616A (zh) 1999-11-03
JP2000053699A (ja) 2000-02-22
EP0953576B1 (en) 2005-11-02
US20070191274A1 (en) 2007-08-16
EP0953576A1 (en) 1999-11-03
NZ335385A (en) 2000-09-29
US6818623B2 (en) 2004-11-16
MA26625A1 (fr) 2004-12-20
US20030139574A1 (en) 2003-07-24
DE69928040D1 (de) 2005-12-08
CA2269221A1 (en) 1999-10-30
DE69928040T2 (de) 2006-07-27
US6468978B1 (en) 2002-10-22
NO992090D0 (no) 1999-04-29
HUP9901411A2 (hu) 1999-12-28
IL129620A (en) 2009-06-15
EP1557427A3 (en) 2005-10-19
NO992090L (no) 1999-11-01
JP3433136B2 (ja) 2003-08-04

Similar Documents

Publication Publication Date Title
SG80028A1 (en) Active hedgehog protein conjugate, process for its production and use
BR0012926A (pt) Polipeptìdeos quiméricos, método para a sua produção e seus usos
FI973048A (fi) Menetelmät ja koostumukset hydrofiilisten molekyylien lipidisoimiseksi
ATE204881T1 (de) Chimäre lipidkörper-pro-grf analoge mit erhöheter biologischer potenz
SG66753A1 (en) A recombinant human factor viii derivative
CO4830493A1 (es) Anticuerpos contra cd40 humano
MX172600B (es) , "procedimiento para la produccion de una proteina biologicamente activa
BG101213A (en) Synthetic stimulation amino acids
SE9100799D0 (sv) Recombinant human factor viii derivatives
ATE117559T1 (de) Verfahren zur präparierung von biologischem implantationsmaterial.
GR3018691T3 (en) Amino acids, peptides or derivatives thereof coupled to fats
AU4422797A (en) Methods and compositions for generating angiostatin
IL131381A0 (en) Therapeutic agent for lymphatic tumors
EP1762574A3 (en) Chemical modification of proteins to improve biocompatibility and bioactivity
CA2303395A1 (en) Treatment of obesity
GB8727045D0 (en) Immunoglobulin e competitor
WO2002058589A3 (en) Agents and methods for promoting bone growth
IL93425A0 (en) Modified pseudomonas exotoxin,its production and pharmaceutical compositions containing it
DE3370026D1 (en) Biologically active conjugates and their preparation and use
PT918795E (pt) Droga antiangiogenica para tratar cancro artrite e retinopatia
BR9903169A (pt) Conjugado de proteìna de ouriço-cacheiro ativa, processo para sua produção e uso
DE68902212D1 (de) Immunotoxine zur behandlung bzw. prophylaxe von autoimmunkrankheiten.
ATE282088T1 (de) Aminopeptidase, welche von bacillus licheniformis abstammt und verfahren zur herstellung von proteinen des natürlichen typs
ES477676A1 (es) Procedimiento de preparar alimentos con alto contenido de peptidos, particularmente para animales.